Biotech Incyte Corp. said Monday its board has approved a share buyback of up to $2 billion and the company has commenced a modified Dutch auction tender for up to $1.67 billion worth. The news sent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results